Treatment Approach for Normocytic Anemia with Functional Iron Deficiency and Elevated B12
This patient requires intravenous iron supplementation as first-line therapy, as the combination of low transferrin saturation (20.59%) with elevated ferritin (181 ng/mL) indicates functional iron deficiency (anemia of inflammation), which responds poorly to oral iron. 1
Understanding the Laboratory Pattern
Your patient presents with a classic pattern of functional iron deficiency (also called iron-restricted erythropoiesis):
- Transferrin saturation <20% indicates insufficient iron available for red blood cell production 1, 2
- Elevated ferritin (181 ng/mL) with low iron saturation suggests iron sequestration due to inflammation, where hepcidin upregulation prevents iron release from stores 1
- Normocytic anemia (MCV 91.5) with hemoglobin 8.6 g/dL represents moderate anemia requiring intervention 1
- Markedly elevated B12 (1737 pg/mL) is likely a red herring and does not require treatment in this context 3
Primary Treatment: Intravenous Iron
Intravenous iron is superior to oral iron when ferritin >100 ng/mL with low transferrin saturation, as inflammation-mediated hepcidin upregulation blocks intestinal iron absorption 1:
- Iron sucrose 200 mg IV infusions or ferric carboxymaltose are preferred formulations 1
- Studies in similar patients show hemoglobin increases of 1-3 g/dL within 6-10 weeks of IV iron therapy 1
- No test dose required for iron sucrose or ferric carboxymaltose 1
Why Not Oral Iron?
- Only 21% of patients with functional iron deficiency respond to oral iron after 4 weeks, compared to 65% with IV iron 1
- Oral iron further increases hepcidin levels, paradoxically worsening iron absorption 1
- The elevated ferritin indicates iron is present but sequestered, not absent 1
The Elevated B12: Clinical Significance
Do not treat the elevated B12 level—it is not causing the anemia and supplementation is contraindicated:
- Elevated B12 can occur with inflammation and does not indicate toxicity 3
- Importantly, B12 deficiency can mask iron deficiency by reducing erythropoiesis and falsely elevating iron parameters 3, 4
- However, your patient has the opposite scenario: very high B12 with clear functional iron deficiency 3
- The research showing B12 deficiency masking iron deficiency actually supports that once B12 is replete (as in your patient), the iron deficiency becomes apparent and requires treatment 3, 4
Monitoring Strategy
Recheck hemoglobin at 2-4 weeks, then complete iron panel at 8-10 weeks after IV iron 2:
- Do not recheck ferritin immediately after IV iron—it will be falsely elevated 2
- Target transferrin saturation >20% and ferritin 100-300 ng/mL 1
- If hemoglobin remains <10 g/dL after 8 weeks despite adequate iron repletion, consider erythropoietin-stimulating agents 1
Essential Workup Before Treatment
Rule out underlying causes of inflammation and blood loss:
- Evaluate for chronic kidney disease (check creatinine/GFR) as this commonly causes functional iron deficiency 1
- Screen for gastrointestinal pathology including malignancy if any GI symptoms present 1
- Check inflammatory markers (CRP) to confirm inflammatory state 1
- Thyroid function testing should be performed as hypothyroidism can contribute to anemia 1
Common Pitfalls to Avoid
- Do not prescribe oral iron first when ferritin is elevated—this wastes time and the patient will likely not respond 1
- Do not supplement B12 despite the low reticulocyte count (1.97%)—the elevated B12 level indicates adequate stores 3
- Do not wait for ferritin to drop below 100 before treating—functional iron deficiency requires treatment even with ferritin 100-300 ng/mL when transferrin saturation is low 1
- Avoid checking ferritin within 8 weeks of IV iron as it will remain artificially elevated 2